COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about attendance requirements for live courses and conferences and available COVID-19 online education and resources.
Epizyme - Exhibitor

Company Website

Contact Information:

Janet Huss

Virtual Exhibit Hall Home

Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit

Join us for a virtual meeting room for August 20 and August 21

August 20:
August 21:

Additional Information
Tazverik in Follicular Lymphoma
Package Insert
Epizyme Now Patient Support Program